Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 15
1979 22
1980 10
1981 9
1982 8
1983 9
1984 16
1985 11
1986 16
1987 9
1988 10
1989 10
1990 12
1991 6
1992 8
1993 4
1994 8
1995 7
1996 10
1997 14
1998 12
1999 21
2000 21
2001 18
2002 14
2003 16
2004 30
2005 18
2006 21
2007 14
2008 16
2009 5
2010 10
2011 15
2012 9
2013 8
2014 2
2015 3
2016 4
2017 5
2018 1
2019 2
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

468 results
Results by year
Filters applied: . Clear all
Page 1
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.
Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN. Symmans WF, et al. Among authors: buzdar au. J Clin Oncol. 2017 Apr 1;35(10):1049-1060. doi: 10.1200/JCO.2015.63.1010. Epub 2017 Jan 30. J Clin Oncol. 2017. PMID: 28135148 Free PMC article.
Anastrozole.
Kelly CM, Buzdar AU. Kelly CM, et al. Among authors: buzdar au. Expert Opin Drug Saf. 2010 Nov;9(6):995-1003. doi: 10.1517/14740338.2010.515977. Expert Opin Drug Saf. 2010. PMID: 20923259 Review.
Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.
Mittendorf EA, Jeruss JS, Tucker SL, Kolli A, Newman LA, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Mittendorf EA, et al. Among authors: buzdar au. J Clin Oncol. 2011 May 20;29(15):1956-62. doi: 10.1200/JCO.2010.31.8469. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21482989 Free PMC article.
Evolving novel anti-HER2 strategies.
Jones KL, Buzdar AU. Jones KL, et al. Among authors: buzdar au. Lancet Oncol. 2009 Dec;10(12):1179-87. doi: 10.1016/S1470-2045(09)70315-8. Lancet Oncol. 2009. PMID: 19959074 Review.
Breast cancer in men.
Buzdar AU. Buzdar AU. Oncology (Williston Park). 2003 Oct;17(10):1361-4; discussion 1364, 1369-72. Oncology (Williston Park). 2003. PMID: 14606362 Free article. Review.
Breast cancer in men.
Giordano SH, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Ann Intern Med. 2002 Oct 15;137(8):678-87. doi: 10.7326/0003-4819-137-8-200210150-00013. Ann Intern Med. 2002. PMID: 12379069 Review.
Aromatase inhibitors: current status.
Ibrahim NK, Buzdar AU. Ibrahim NK, et al. Among authors: buzdar au. Am J Clin Oncol. 1995 Oct;18(5):407-17. doi: 10.1097/00000421-199510000-00010. Am J Clin Oncol. 1995. PMID: 7572758 Review.
TAS-108: a novel steroidal antiestrogen.
Buzdar AU. Buzdar AU. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):906s-8s. Clin Cancer Res. 2005. PMID: 15701885 Free article. Review.
Making genuine progress against metastatic breast cancer.
Lyman GH, Burstein HJ, Buzdar AU, D'Agostino R, Ellis PA. Lyman GH, et al. Among authors: buzdar au. J Clin Oncol. 2012 Oct 1;30(28):3448-51. doi: 10.1200/JCO.2012.43.6931. Epub 2012 Aug 27. J Clin Oncol. 2012. PMID: 22927527 Review. No abstract available.
468 results